TBXT and Beyond ASPIRE Awards: Expanding the Chordoma Surfaceome

The Mark Foundation for Cancer Research and the Chordoma Foundation invite proposals that accelerate the development of new strategies to target the chordoma surfaceome. Specifically, projects that advance the understanding and therapeutic targeting of TBXT pMHC, as well as additional tumor-specific surface antigens.

Funding: $500,000 total 

Duration: 2 years

Research Authority due date; 3.12.26

Concept note (required) due date: 10.12.26

Full application due date: 1.3.27